Authors:
Bellobuono, A
Mondazzi, L
Tempini, S
Chiodo, F
Magliano, E
Furione, L
Ideo, G
Citation: A. Bellobuono et al., Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy, J HEPATOL, 33(3), 2000, pp. 463-468
Authors:
Ideo, G
Bellobuono, A
Tempini, S
Mondazzi, L
Airoldi, A
Benetti, G
Bissoli, F
Cestari, C
Colombo, E
Del Poggio, P
Fracassetti, O
Lazzaroni, S
Marelli, A
Paris, B
Prada, A
Rainer, E
Roffi, L
Citation: G. Ideo et al., Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study, EUR J GASTR, 11(11), 1999, pp. 1203-1207
Authors:
Bellobuono, A
Mondazzi, L
Tempini, S
Chiodo, F
Magliano, E
Mondini, C
Ideo, G
Citation: A. Bellobuono et al., Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?, J HEPATOL, 30(1), 1999, pp. 8-13
Authors:
Schalm, SW
Weiland, O
Hansen, BE
Milella, M
Lai, FY
Hollander, A
Michielsen, PP
Bellobuono, A
Chemello, L
Pastore, G
Chen, DS
Brouwer, JT
Citation: Sw. Schalm et al., Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials, GASTROENTY, 117(2), 1999, pp. 408-413